Curis, Inc is focused on developing innovative therapeutics for the treatment of cancer, specifically targeting hematologic malignancies and other cancers. This includes their marketed product, Erivedge, and several drugs in their pipeline.

Curis, Inc

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

COM:CURIS

Curis, Inc

Last Close

4.10

22/11 21:00

Market Cap

34.12M

Beta: -

Volume Today

107.98K

Avg: -

Filings Not Available